Cite
HARVARD Citation
Heldman, M. et al. (2023). Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients. Transplant infectious disease. 24 (6), p. n/a. [Online].